Metabolic & weight · Peptide
AOD-9604
Also known as GH fragment 176-191
A growth-hormone fragment studied for fat metabolism without GH's growth effects.
Status as of 2026-07 · reclassification ≠ FDA approval · educational only, not medical advice.
The signal it sends
May stimulate fat breakdown (lipolysis) without raising blood sugar like full GH.
Benefits & effects studied
- Fat-metabolism research
- Cartilage-repair interest
Research state
Human fat-loss evidence is weak. Not approved for weight loss.
Dosing & pharmacokinetics
Investigational. Half-life: Short.
Dosing information is educational only. AOD-9604 decisions belong with a licensed clinician — Jevity does not recommend or supply dosing.
History & discovery
First described 1990s-2000s by Metabolic Pharmaceuticals (Australia) Origin: Developed by Australian firm Metabolic Pharmaceuticals from the C-terminal fat-metabolizing fragment of human growth hormone (residues 176-191), stabilized by adding a tyrosine residue; it failed its Phase 2b weight-loss endpoint in 2007 but gained FDA GRAS status as a food ingredient in 2014..
Molecular structure
A modified 16-amino-acid fragment of human growth hormone (residues 176-191) with an added N-terminal tyrosine.
Frequently asked questions
Is AOD-9604 FDA-approved?
Not FDA-approved; compoundable (removed Cat 2, Sep 2024) On Jevity's evidence scale, AOD-9604 is graded "In human trials". Reclassification for compounding is not the same as FDA approval.
What is AOD-9604 used for?
A growth-hormone fragment studied for fat metabolism without GH's growth effects. May stimulate fat breakdown (lipolysis) without raising blood sugar like full GH. Studied effects include: Fat-metabolism research; Cartilage-repair interest. This is educational information, not a recommendation to use it.
Is AOD-9604 legal in the UAE?
UAE / DHA status: Prescription-only via a DHA-licensed clinic
Is AOD-9604 banned in sport?
WADA status: Verify on current WADA list
What is AOD-9604's Jevity Score?
AOD-9604 has a Jevity Score of 58/100 — a proprietary composite of evidence strength (7/10), regulatory clarity (5/10) and supply verifiability (4/10). It reflects how established and legitimate the compound is, not a recommendation.
AOD-9604 is prescription-only or research-only. A licensed clinician must evaluate whether it's appropriate for you.
Book a consult →Related metabolic & weight peptides
Educational information only — not medical advice, a diagnosis, or a recommendation to use any substance or therapy. Regulatory status changes; verify current rules and any personal decision with a licensed clinician. Jevity is operated by Upcapital Global FZCO, Dubai, UAE.